Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | ADRX-0706 |
Synonyms | |
Therapy Description |
ADRX-0706 is an antibody-drug conjugate (ADC) targeting NECTIN4 that potentially inhibits tumor growth (Cancer Res (2024) 84 (6_Supplement): 1891). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
ADRX-0706 | ADRX0706|ADRX 0706 | ADRX-0706 is an antibody-drug conjugate (ADC) targeting NECTIN4 that potentially inhibits tumor growth (Cancer Res (2024) 84 (6_Supplement): 1891). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT06036121 | Phase I | ADRX-0706 | A Study of ADRX-0706 in Select Advanced Solid Tumors | Recruiting | USA | 1 |